Skip to content

Immediate effects of 850 nm Diode Laser on patients with Cervical Myofascial Pain Syndrome: a Randomized-controlled trial

Immediate effects of 850 nm Diode Laser on patients with Cervical Myofascial Pain Syndrome: a Randomized-controlled trial

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
PACTR
Registry ID
PACTR202306638021904
Enrollment
24
Registered
2023-06-20
Start date
2021-07-31
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Musculoskeletal Diseases

Interventions

Laser therapy
control group

Sponsors

Ahmed Ali Zahreldin
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: -Adults; over 18 years old. -Diagnosis of MPS in accordance with Travell and Simons' criteria. -Had active and palpable TrPs with pain duration less than one week.

Exclusion criteria

Exclusion criteria: fractures or open wound, other neuro-musculo-skeletal disorders causes neck pain such as fibromyalgia, cervical disc lesion, radiculopathy or myelopathy, other systemic diseases, previous surgical procedures, or recent trigger point injection.

Design outcomes

Primary

MeasureTime frame
Pain intensity, pressure pain threshold, and cervical range of motion

Countries

Egypt

Contacts

Public ContactAhmed Ali

Medical Applications of Lasers in Physical Therapy National Institute of Laser Enhanced Sciences Cairo University Egypt

ahmed_zahreldin@stud.cu.edu.eg+201112193896

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Aug 9, 2026